LIFITEGRAST

LIFITEGRAST was reported 16505 times

LIFITEGRAST is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 INSTILLATION SITE REACTION 1019 0.9349
1 INSTILLATION SITE LACRIMATION 179 0.7397
2 INSTILLATION SITE INFLAMMATION 33 0.5893
3 INSTILLATION SITE HYPERSENSITIVITY 13 0.5652
4 INSTILLATION SITE BURN 24 0.5581
5 INSTILLATION SITE PAIN 1283 0.5173
6 INSTILLATION SITE DISCOMFORT 68 0.5075
7 INSTILLATION SITE PRURITUS 189 0.5013
8 INSTILLATION SITE RASH 6 0.4615
9 INSTILLATION SITE DISCHARGE 118 0.4487
10 INSTILLATION SITE SWELLING 76 0.4343
11 INSTILLATION SITE ERYTHEMA 210 0.3977
12 INSTILLATION SITE DRYNESS 47 0.3643
13 INSTILLATION SITE FOREIGN BODY SENSATION 39 0.2690
14 INSTILLATION SITE PARAESTHESIA 10 0.2381
15 INSTILLATION SITE VESICLES 4 0.2353
16 INSTILLATION SITE IRRITATION 248 0.2095
17 INSTILLATION SITE INFECTION 9 0.1915
18 INSTILLATION SITE COMPLICATION 4 0.1905
19 VITAL DYE STAINING CORNEA PRESENT 6 0.1765
20 INSTILLATION SITE HAEMORRHAGE 6 0.1538
21 PRODUCT AFTER TASTE 73 0.0765
22 BLOOD FOLATE DECREASED 44 0.0605
23 DEAFNESS PERMANENT 11 0.0561
24 PERIORBITAL PAIN 46 0.0543
25 EYE IRRITATION 2780 0.0482
26 EYELID MARGIN CRUSTING 134 0.0463
27 SUPERFICIAL INJURY OF EYE 50 0.0457
28 DACRYOCYSTITIS 7 0.0455
29 THERMAL BURNS OF EYE 9 0.0398
30 EYE DISCHARGE 403 0.0387
31 SWOLLEN TEAR DUCT 4 0.0377
32 EYELID PAIN 76 0.0374
33 EYE PARAESTHESIA 5 0.0318
34 PRODUCT CONTAINER ISSUE 271 0.0316
35 CORNEAL DEFECT 4 0.0303
36 LACRIMATION DECREASED 14 0.0295
37 FOREIGN BODY SENSATION IN EYES 188 0.0295
38 CORNEAL EXFOLIATION 3 0.0294
39 EYELASH CHANGES 5 0.0282
40 DACRYOSTENOSIS ACQUIRED 35 0.0271
41 EYE PAIN 1460 0.0259
42 OCULAR ROSACEA 5 0.0246
43 MEIBOMIAN GLAND DYSFUNCTION 11 0.0243
44 PRODUCT DELIVERY MECHANISM ISSUE 130 0.0242
45 PRODUCT USE COMPLAINT 376 0.0238
46 DRY EYE 1187 0.0238
47 OCULAR DISCOMFORT 261 0.0232
48 CORNEAL LESION 7 0.0227
49 CORNEAL ABRASION 31 0.0226
50 EYELID RASH 22 0.0225
51 EYE COMPLICATION ASSOCIATED WITH DEVICE 6 0.0223
52 ULCERATIVE KERATITIS 60 0.0219
53 CORNEAL SCAR 11 0.0219
54 CHALAZION 14 0.0218
55 CORNEAL REFLEX DECREASED 8 0.0213
56 EYELID IRRITATION 53 0.0211
57 LACRIMATION INCREASED 636 0.0210
58 EYE ULCER 12 0.0208
59 PATIENT DISSATISFACTION WITH TREATMENT 40 0.0207
60 PUNCTATE KERATITIS 19 0.0207
61 DERMATOCHALASIS 3 0.0204
62 PRODUCT DESIGN ISSUE 14 0.0196
63 VISION BLURRED 2679 0.0195
64 PRODUCT KNOWLEDGE DEFICIT 15 0.0192
65 CORNEAL DYSTROPHY 8 0.0191
66 LACRIMAL DISORDER 11 0.0189
67 PACKAGING DESIGN ISSUE 6 0.0182
68 EYELID EXFOLIATION 14 0.0177
69 EYELID THICKENING 5 0.0175
70 ENDOCRINE OPHTHALMOPATHY 15 0.0173
71 ABNORMAL SENSATION IN EYE 74 0.0172
72 CORNEAL EROSION 9 0.0167
73 FOREIGN BODY IN EYE 16 0.0167
74 DYSGEUSIA 1118 0.0150
75 OCULAR HYPERAEMIA 707 0.0149
76 PERIORBITAL IRRITATION 5 0.0146
77 TEMPOROMANDIBULAR PAIN AND DYSFUNCTION SYNDROME 6 0.0141
78 EYELID DISORDER 32 0.0139
79 SWELLING OF EYELID 87 0.0138
80 GLARE 7 0.0136
81 INJURY CORNEAL 7 0.0135
82 EYE PRURITUS 446 0.0133
83 GRAFT VERSUS HOST DISEASE IN EYE 3 0.0130
84 ERYTHEMA OF EYELID 69 0.0127
85 PERIORBITAL SWELLING 72 0.0127
86 BLEPHARITIS 51 0.0127
87 EYE INJURY 38 0.0125
88 CORNEAL DEGENERATION 3 0.0124
89 CENTRAL SLEEP APNOEA SYNDROME 4 0.0123
90 EUSTACHIAN TUBE DYSFUNCTION 7 0.0122
91 ASTHENOPIA 66 0.0120
92 CORNEAL DISORDER 26 0.0118
93 CORNEAL THINNING 3 0.0117
94 CONJUNCTIVAL OEDEMA 12 0.0117
95 POSTERIOR CAPSULE OPACIFICATION 4 0.0117
96 SINUS PAIN 27 0.0116
97 PRODUCT DROPPER ISSUE 9 0.0114
98 EYELID OPERATION 3 0.0112
99 EPIRETINAL MEMBRANE 3 0.0108
100 PRODUCT CLOSURE REMOVAL DIFFICULT 11 0.0108
101 DENTAL PLAQUE 3 0.0108
102 OPHTHALMIC HERPES SIMPLEX 6 0.0104
103 EYE DISORDER 338 0.0103
104 PHOTOPHOBIA 188 0.0100
105 EYELID SKIN DRYNESS 12 0.0099
106 EYE COLOUR CHANGE 10 0.0098
107 LAGOPHTHALMOS 4 0.0098
108 TASTE DISORDER 195 0.0096
109 WRONG DOSE 23 0.0095
110 PERIORBITAL CELLULITIS 5 0.0093
111 PRESBYOPIA 5 0.0090
112 PRODUCT CLOSURE ISSUE 5 0.0090
113 EYE INFECTION BACTERIAL 5 0.0090
114 ECTROPION 3 0.0089
115 PRODUCT PACKAGING DIFFICULT TO OPEN 23 0.0088
116 EYE INFECTION 99 0.0088
117 EYE INFLAMMATION 83 0.0087
118 EYELIDS PRURITUS 27 0.0087
119 HORDEOLUM 37 0.0085
120 GASTROINTESTINAL MICROORGANISM OVERGROWTH 3 0.0085
121 EYE BURNS 5 0.0085
122 EYE ALLERGY 13 0.0084
123 METAMORPHOPSIA 15 0.0081
124 EXCESSIVE EYE BLINKING 12 0.0081
125 CONJUNCTIVITIS ALLERGIC 12 0.0081
126 EYE SWELLING 283 0.0076
127 EYELID FUNCTION DISORDER 6 0.0076
128 PRODUCT CONTAINER SEAL ISSUE 13 0.0075
129 KERATITIS 22 0.0072
130 INTRAOCULAR PRESSURE TEST ABNORMAL 5 0.0071
131 HALO VISION 8 0.0071
132 HEARING AID USER 3 0.0070
133 HYPOAESTHESIA EYE 4 0.0068
134 PRODUCT RESIDUE PRESENT 36 0.0067
135 APPENDIX DISORDER 9 0.0064
136 CORNEAL PERFORATION 4 0.0063
137 PRODUCT DISPENSING ISSUE 27 0.0063
138 INABILITY TO AFFORD MEDICATION 62 0.0062
139 PRODUCT PACKAGING ISSUE 59 0.0062
140 RHINALGIA 17 0.0062
141 SCLERAL DISCOLOURATION 4 0.0061
142 UPPER-AIRWAY COUGH SYNDROME 50 0.0061
143 CATARACT NUCLEAR 4 0.0060
144 PRODUCT TASTE ABNORMAL 77 0.0057
145 BLINDNESS TRANSIENT 41 0.0056
146 FRUSTRATION TOLERANCE DECREASED 44 0.0054
147 DRY AGE-RELATED MACULAR DEGENERATION 6 0.0054
148 BUNION OPERATION 3 0.0053
149 LIQUID PRODUCT PHYSICAL ISSUE 39 0.0053
150 INCREASED VISCOSITY OF UPPER RESPIRATORY SECRETION 4 0.0052
151 CORNEAL EPITHELIUM DEFECT 3 0.0052
152 CONJUNCTIVAL HYPERAEMIA 18 0.0050
153 NEOVASCULAR AGE-RELATED MACULAR DEGENERATION 7 0.0050
154 CONJUNCTIVAL HAEMORRHAGE 19 0.0050
155 SUSPECTED PRODUCT CONTAMINATION 5 0.0049
156 ARTHROPOD STING 8 0.0048
157 VISUAL IMPAIRMENT 587 0.0047
158 EYE CONTUSION 10 0.0047
159 NASAL DISCOMFORT 37 0.0047
160 HERPES OPHTHALMIC 6 0.0045
161 BURNING SENSATION 317 0.0045
162 ALLERGIC REACTION TO EXCIPIENT 9 0.0045
163 PRODUCT OUTER PACKAGING ISSUE 4 0.0044
164 EYE HAEMORRHAGE 59 0.0044
165 INCORRECT DOSE ADMINISTERED BY PRODUCT 7 0.0044
166 NASAL DISCHARGE DISCOLOURATION 6 0.0043
167 PRODUCT EXPIRATION DATE ISSUE 6 0.0043
168 MAST CELL ACTIVATION SYNDROME 6 0.0043
169 MULTIPLE USE OF SINGLE-USE PRODUCT 24 0.0043
170 GLASSY EYES 3 0.0042
171 PARANASAL SINUS DISCOMFORT 16 0.0042
172 HYPERMETROPIA 4 0.0042
173 VITREOUS FLOATERS 41 0.0042
174 MADAROSIS 48 0.0041
175 TREATMENT DELAYED 7 0.0040
176 PRODUCT PACKAGE ASSOCIATED INJURY 9 0.0040
177 CORNEAL DEPOSITS 3 0.0040
178 NASAL OEDEMA 7 0.0039
179 SLEEP DEFICIT 8 0.0038
180 SINUS DISORDER 73 0.0037
181 PRODUCT LABEL ISSUE 25 0.0037
182 CORNEAL OPACITY 5 0.0037
183 BALANOPOSTHITIS 3 0.0036
184 DEAFNESS NEUROSENSORY 12 0.0036
185 MACULAR DEGENERATION 43 0.0036
186 READING DISORDER 8 0.0035
187 PORPHYRIA ACUTE 5 0.0035
188 LUMBAR RADICULOPATHY 4 0.0035
189 GLAUCOMA 65 0.0034
190 OPHTHALMIC HERPES ZOSTER 6 0.0033
191 CERUMEN IMPACTION 3 0.0033
192 RETINAL TEAR 8 0.0032
193 OROPHARYNGEAL DISCOMFORT 29 0.0032
194 PRODUCT DEPOSIT 5 0.0032
195 HYPERAEMIA 6 0.0030
196 EYE OPERATION 14 0.0030
197 CONJUNCTIVITIS 56 0.0030
198 BLINDNESS 122 0.0030
199 EAR HAEMORRHAGE 6 0.0030
200 MYOPIA 7 0.0029
201 DISCHARGE 4 0.0029
202 EYELID OEDEMA 33 0.0028
203 AUDITORY DISORDER 4 0.0028
204 CONNECTIVE TISSUE DISORDER 4 0.0028
205 EXPOSURE VIA SKIN CONTACT 71 0.0027
206 PRODUCT QUALITY ISSUE 371 0.0027
207 PRODUCT ADMINISTRATION ERROR 55 0.0027
208 PRODUCT PHYSICAL CONSISTENCY ISSUE 15 0.0027
209 CORNEAL OEDEMA 6 0.0027
210 PAROSMIA 20 0.0026
211 ASTIGMATISM 4 0.0026
212 CARBON DIOXIDE DECREASED 3 0.0026
213 CHEMICAL BURN 3 0.0026
214 HYPOACUSIS 112 0.0026
215 TONGUE DISCOMFORT 11 0.0026
216 ORAL MUCOSAL ERYTHEMA 4 0.0026
217 SECRETION DISCHARGE 32 0.0026
218 BLEPHAROSPASM 16 0.0025
219 THROAT IRRITATION 114 0.0025
220 PHARYNGEAL PARAESTHESIA 4 0.0025
221 NIGHT BLINDNESS 4 0.0025
222 PHYSICAL DISABILITY 11 0.0025
223 EYE OEDEMA 6 0.0024
224 SHOULDER FRACTURE 4 0.0024
225 EXPIRED PRODUCT ADMINISTERED 81 0.0024
226 EAR DISCOMFORT 25 0.0024
227 STRABISMUS 7 0.0024
228 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 80 0.0024
229 CATARACT OPERATION 14 0.0024
230 SINUS HEADACHE 14 0.0024
231 APPLICATION SITE WARMTH 3 0.0024
232 PRODUCT COLOUR ISSUE 12 0.0023
233 EXOPHTHALMOS 5 0.0023
234 ACUTE SINUSITIS 4 0.0023
235 RECALLED PRODUCT 4 0.0023
236 PRODUCT ADMINISTRATION INTERRUPTED 18 0.0023
237 INFUSION SITE DISCHARGE 4 0.0023
238 OESOPHAGEAL PAIN 9 0.0023
239 ACROCHORDON 3 0.0023
240 AUTOIMMUNE DISORDER 22 0.0023
241 TEMPOROMANDIBULAR JOINT SYNDROME 6 0.0022
242 FACIAL PAIN 20 0.0022
243 PRODUCT AVAILABILITY ISSUE 51 0.0022
244 NASAL DRYNESS 14 0.0022
245 VISUAL ACUITY REDUCED 74 0.0022
246 PHOTOPSIA 14 0.0022
247 CARBON DIOXIDE INCREASED 3 0.0022
248 THERAPEUTIC PRODUCT EFFECT DELAYED 10 0.0022
249 CUTANEOUS VASCULITIS 8 0.0022
250 MEAN CELL HAEMOGLOBIN DECREASED 4 0.0022
251 DRY THROAT 22 0.0022
252 CATARACT 128 0.0021
253 PRODUCT COMPLAINT 54 0.0021
254 WHITE BLOOD CELLS URINE POSITIVE 4 0.0021
255 INTRAOCULAR PRESSURE INCREASED 27 0.0021
256 FACE INJURY 8 0.0021
257 PARANASAL SINUS HYPERSECRETION 8 0.0021
258 INSURANCE ISSUE 32 0.0021
259 GINGIVAL RECESSION 4 0.0021
260 HYPOTHALAMO-PITUITARY DISORDER 3 0.0021
261 OCULAR HYPERTENSION 4 0.0021
262 BLINDNESS UNILATERAL 29 0.0021
263 NASAL SEPTUM DEVIATION 4 0.0020
264 HYPERSENSITIVITY 379 0.0020
265 DARK CIRCLES UNDER EYES 3 0.0020
266 VOCAL CORD DISORDER 4 0.0020
267 IMPAIRED DRIVING ABILITY 23 0.0020
268 ADHESION 3 0.0020
269 ARTHRITIS 156 0.0020
270 SINUSITIS 201 0.0020
271 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 12 0.0019
272 ROSACEA 9 0.0019
273 DERMATITIS CONTACT 22 0.0019
274 RETINAL DISORDER 5 0.0019
275 PRODUCT DOSE OMISSION 125 0.0019
276 EAR SWELLING 4 0.0019
277 VITREOUS DETACHMENT 4 0.0018
278 AGEUSIA 46 0.0018
279 CHAPPED LIPS 8 0.0018
280 PHARYNGEAL SWELLING 18 0.0018
281 PRODUCT DOSE OMISSION IN ERROR 52 0.0018
282 SNEEZING 41 0.0018
283 MIDDLE EAR EFFUSION 4 0.0018
284 PRODUCT LOT NUMBER ISSUE 4 0.0018
285 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 127 0.0018
286 PIGMENTATION DISORDER 11 0.0018
287 DIPLOPIA 46 0.0018
288 SEASONAL ALLERGY 25 0.0018
289 DRUG EFFECT DELAYED 8 0.0018
290 EYE MOVEMENT DISORDER 12 0.0018
291 PRODUCT TEMPERATURE EXCURSION ISSUE 9 0.0017
292 ORAL PRURITUS 4 0.0017
293 RESPIRATORY TRACT INFECTION VIRAL 4 0.0017
294 RHINORRHOEA 111 0.0017
295 SPINAL STENOSIS 7 0.0017
296 MACULOPATHY 6 0.0017
297 FOOD ALLERGY 13 0.0017
298 IMPAIRED QUALITY OF LIFE 24 0.0017
299 APHONIA 23 0.0016
300 PURULENT DISCHARGE 7 0.0016
301 INCORRECT DOSAGE ADMINISTERED 8 0.0016
302 BODY TEMPERATURE ABNORMAL 3 0.0016
303 SINUS CONGESTION 22 0.0016
304 DENTAL CARE 3 0.0016
305 ACCIDENTAL EXPOSURE TO PRODUCT 167 0.0016
306 CONCOMITANT DISEASE AGGRAVATED 10 0.0016
307 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 287 0.0016
308 CYSTOID MACULAR OEDEMA 3 0.0016
309 PRODUCT PRESCRIBING ISSUE 34 0.0016
310 MEAN CELL VOLUME INCREASED 4 0.0016
311 MENOPAUSE 4 0.0016
312 THERMAL BURN 11 0.0015
313 PRODUCT DOSE OMISSION ISSUE 454 0.0015
314 PRODUCT SUPPLY ISSUE 11 0.0015
315 HYPOGEUSIA 3 0.0015
316 EAR DISORDER 7 0.0015
317 DRUG DELIVERY SYSTEM ISSUE 3 0.0015
318 ADVERSE REACTION 20 0.0015
319 BLOOD POTASSIUM ABNORMAL 4 0.0015
320 SKIN DISCOMFORT 4 0.0015
321 DISCOMFORT 90 0.0015
322 VIRAL UPPER RESPIRATORY TRACT INFECTION 7 0.0015
323 DRY MOUTH 117 0.0014
324 TRICHORRHEXIS 4 0.0014
325 INFUSION SITE SWELLING 9 0.0014
326 PRODUCT CONTAMINATION 5 0.0014
327 MULTIPLE ALLERGIES 11 0.0014
328 MYDRIASIS 18 0.0014
329 LIP PAIN 4 0.0014
330 PHOTOSENSITIVITY REACTION 23 0.0014
331 BONE LESION 5 0.0014
332 OROPHARYNGEAL PAIN 128 0.0014
333 FINE MOTOR SKILL DYSFUNCTION 4 0.0014
334 TOOTHACHE 25 0.0014
335 SWOLLEN TONGUE 43 0.0014
336 WRONG PATIENT RECEIVED PRODUCT 4 0.0014
337 PRODUCT COMMUNICATION ISSUE 12 0.0014
338 DRUG EFFECT LESS THAN EXPECTED 20 0.0013
339 RHINITIS ALLERGIC 6 0.0013
340 TENDON INJURY 5 0.0013
341 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 271 0.0013
342 ILLNESS 137 0.0013
343 HYPOAESTHESIA ORAL 20 0.0013
344 IRITIS 4 0.0013
345 SENSATION OF FOREIGN BODY 11 0.0013
346 ORAL DISCOMFORT 18 0.0013
347 INFUSION SITE PRURITUS 4 0.0013
348 IRIDOCYCLITIS 4 0.0013
349 OESOPHAGEAL CANDIDIASIS 5 0.0013
350 ILL-DEFINED DISORDER 76 0.0012
351 PRODUCT STORAGE ERROR 109 0.0012
352 ANOSMIA 18 0.0012
353 DRUG INEFFECTIVE 1629 0.0012
354 POOR QUALITY PRODUCT ADMINISTERED 13 0.0012
355 BREATH ODOUR 3 0.0012
356 TRIGGER FINGER 5 0.0012
357 INCORRECT PRODUCT STORAGE 16 0.0012
358 BLOOD IMMUNOGLOBULIN G DECREASED 3 0.0012
359 PRODUCT USE ISSUE 226 0.0012
360 DEVICE USE ISSUE 21 0.0012
361 RETINAL DETACHMENT 11 0.0012
362 BACK INJURY 13 0.0012
363 DEAFNESS 31 0.0012
364 DERMATOMYOSITIS 3 0.0012
365 EAR PAIN 23 0.0012
366 LIP SWELLING 39 0.0012
367 SPUTUM DISCOLOURED 11 0.0012
368 SPINAL OSTEOARTHRITIS 10 0.0011
369 TINNITUS 52 0.0011
370 DRUG INTOLERANCE 109 0.0011
371 PRE-EXISTING CONDITION IMPROVED 7 0.0011
372 THERAPEUTIC RESPONSE UNEXPECTED 50 0.0011
373 FACIAL BONES FRACTURE 4 0.0011
374 PARAESTHESIA ORAL 16 0.0011
375 VISUAL FIELD DEFECT 8 0.0011
376 THERAPY INTERRUPTED 78 0.0011
377 FOOT DEFORMITY 12 0.0011
378 ARTHRITIS INFECTIVE 5 0.0011
379 CARPAL TUNNEL SYNDROME 15 0.0011
380 PRODUCT LEAKAGE 6 0.0011
381 THROAT CLEARING 4 0.0011
382 SNORING 4 0.0011
383 NASAL CONGESTION 62 0.0011
384 INTENTIONAL DOSE OMISSION 30 0.0011
385 HEART VALVE INCOMPETENCE 3 0.0010
386 CLAVICLE FRACTURE 4 0.0010
387 BREAST MASS 7 0.0010
388 BLOOD PARATHYROID HORMONE INCREASED 3 0.0010
389 EPISTAXIS 77 0.0010
390 PELVIC FRACTURE 8 0.0010
391 FORMICATION 7 0.0010
392 ULCER 16 0.0010
393 GINGIVAL PAIN 8 0.0010
394 UPPER LIMB FRACTURE 20 0.0010
395 HEADACHE 629 0.0010
396 THROAT TIGHTNESS 27 0.0010
397 OVERDOSE 215 0.0010
398 CEREBROVASCULAR DISORDER 3 0.0010
399 MIGRAINE 95 0.0010
400 ACCIDENTAL OVERDOSE 36 0.0010
401 SPINAL OPERATION 12 0.0010
402 INTERVERTEBRAL DISC DEGENERATION 9 0.0010
403 SCAB 11 0.0010
404 INFUSION SITE EXTRAVASATION 6 0.0010
405 DISABILITY 19 0.0010
406 BLOOD BLISTER 3 0.0010
407 DYSPHONIA 56 0.0010
408 BRAIN FOG 15 0.0010
409 SURGERY 56 0.0010
410 PRODUCT ODOUR ABNORMAL 10 0.0010
411 LEUKAEMIA 9 0.0010
412 FOREIGN BODY IN THROAT 3 0.0010
413 ABDOMINAL ADHESIONS 3 0.0009
414 ATTENTION DEFICIT HYPERACTIVITY DISORDER 4 0.0009
415 DRUG EFFECT INCREASED 3 0.0009
416 INTENTIONAL PRODUCT USE ISSUE 83 0.0009
417 ORAL PAIN 21 0.0009
418 TENSION HEADACHE 4 0.0009
419 HIP SURGERY 5 0.0009
420 BACK DISORDER 15 0.0009
421 GASTROOESOPHAGEAL REFLUX DISEASE 74 0.0009
422 COVID-19 161 0.0009
423 LIGAMENT SPRAIN 9 0.0009
424 CONDITION AGGRAVATED 276 0.0009
425 DEAFNESS UNILATERAL 5 0.0009
426 GINGIVAL SWELLING 4 0.0009
427 LIGAMENT RUPTURE 4 0.0009
428 PURPURA 8 0.0009
429 CONCUSSION 7 0.0009
430 SLEEP APNOEA SYNDROME 17 0.0009
431 INCORRECT DOSE ADMINISTERED 203 0.0009
432 CANDIDA INFECTION 15 0.0009
433 EYELID PTOSIS 9 0.0009
434 BLOOD THYROID STIMULATING HORMONE DECREASED 4 0.0009
435 URINE ABNORMALITY 4 0.0009
436 HAEMOGLOBIN INCREASED 4 0.0009
437 MOUTH SWELLING 5 0.0009
438 PRODUCT DISTRIBUTION ISSUE 8 0.0009
439 RENAL FUNCTION TEST ABNORMAL 4 0.0009
440 VASCULITIS 10 0.0009
441 EAR PRURITUS 3 0.0009
442 BONE EROSION 3 0.0008
443 BRADYKINESIA 5 0.0008
444 GLUCOSE TOLERANCE IMPAIRED 5 0.0008
445 FEELING ABNORMAL 202 0.0008
446 ANKLE FRACTURE 13 0.0008
447 LIMB OPERATION 4 0.0008
448 ADVERSE DRUG REACTION 74 0.0008
449 FIBROMYALGIA 20 0.0008
450 FACIAL PARALYSIS 7 0.0008
451 EXTRA DOSE ADMINISTERED 33 0.0008
452 HYSTERECTOMY 7 0.0008
453 GASTROINTESTINAL SOUNDS ABNORMAL 4 0.0008
454 IMPAIRED GASTRIC EMPTYING 11 0.0008
455 SKIN SWELLING 7 0.0008
456 GLOSSODYNIA 18 0.0008
457 OSTEOARTHRITIS 34 0.0008
458 FLUID INTAKE REDUCED 4 0.0008
459 CHRONIC SINUSITIS 3 0.0008
460 TREATMENT FAILURE 66 0.0008
461 DERMATITIS ALLERGIC 10 0.0008
462 SCREAMING 5 0.0008
463 UNEVALUABLE EVENT 59 0.0008
464 INCREASED UPPER AIRWAY SECRETION 4 0.0008
465 INFUSION SITE PAIN 10 0.0008
466 TRISMUS 4 0.0008
467 LIMB INJURY 21 0.0008
468 VERTIGO 47 0.0008
469 PERIORBITAL OEDEMA 4 0.0008
470 POLYP 5 0.0008
471 ORAL CANDIDIASIS 10 0.0008
472 DYSGRAPHIA 5 0.0008
473 NERVE COMPRESSION 7 0.0008
474 APPETITE DISORDER 5 0.0008
475 SCIATICA 12 0.0008
476 JOINT INJURY 16 0.0007
477 POST-TRAUMATIC STRESS DISORDER 5 0.0007
478 RHINITIS 6 0.0007
479 FEAR 20 0.0007
480 MYASTHENIA GRAVIS 6 0.0007
481 UVEITIS 10 0.0007
482 HEAD DISCOMFORT 13 0.0007
483 ABNORMAL LOSS OF WEIGHT 5 0.0007
484 GOITRE 3 0.0007
485 OESOPHAGITIS 8 0.0007
486 NONSPECIFIC REACTION 4 0.0007
487 ECONOMIC PROBLEM 11 0.0007
488 CHOKING SENSATION 4 0.0007
489 SWELLING FACE 47 0.0007
490 NERVE INJURY 8 0.0007
491 EAR INFECTION 19 0.0007
492 SKIN INFECTION 8 0.0007
493 HAND FRACTURE 5 0.0007
494 MUSCULOSKELETAL DISCOMFORT 12 0.0007
495 PRODUCT PHYSICAL ISSUE 14 0.0007
496 THERAPEUTIC RESPONSE SHORTENED 23 0.0007
497 DIVERTICULUM INTESTINAL 3 0.0007
498 HIP FRACTURE 22 0.0007
499 THERAPY CESSATION 35 0.0007
500 DEMENTIA 19 0.0007
501 SKIN IRRITATION 31 0.0007
502 PRODUCT PRESCRIBING ERROR 16 0.0007
503 ODYNOPHAGIA 4 0.0007
504 DERMATITIS 14 0.0007
505 WRIST FRACTURE 8 0.0007
506 STOMATITIS 40 0.0007
507 BLOOD THYROID STIMULATING HORMONE INCREASED 6 0.0007
508 PRESCRIBED UNDERDOSE 13 0.0007
509 BLOOD CHOLESTEROL ABNORMAL 3 0.0006
510 LOW DENSITY LIPOPROTEIN INCREASED 5 0.0006
511 SCOLIOSIS 4 0.0006
512 PHARYNGITIS 8 0.0006
513 BACTERIAL INFECTION 12 0.0006
514 SPINAL DISORDER 6 0.0006
515 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 45 0.0006
516 ABDOMINAL DISCOMFORT 105 0.0006
517 NEURALGIA 15 0.0006
518 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 4 0.0006
519 SKIN FISSURES 12 0.0006
520 PLATELET COUNT INCREASED 8 0.0006
521 DYSPEPSIA 60 0.0006
522 NECK PAIN 34 0.0006
523 BLOOD PRESSURE INCREASED 93 0.0006
524 HYPERVOLAEMIA 3 0.0006
525 CORONAVIRUS INFECTION 4 0.0006
526 BRAIN INJURY 6 0.0006
527 INFUSION SITE ERYTHEMA 5 0.0006
528 PAIN 364 0.0006
529 NASOPHARYNGITIS 109 0.0006
530 PSORIATIC ARTHROPATHY 24 0.0006
531 PLATELET COUNT DECREASED 63 0.0006
532 ACCIDENT 7 0.0006
533 PHARYNGEAL OEDEMA 9 0.0006
534 THYROID DISORDER 9 0.0006
535 ONYCHOCLASIS 4 0.0006
536 PRURITUS 223 0.0006
537 FOOT FRACTURE 11 0.0006
538 BLISTER 32 0.0006
539 NEOPLASM MALIGNANT 38 0.0006
540 SCRATCH 6 0.0006
541 BRONCHITIS 42 0.0006
542 SKIN DISCOLOURATION 26 0.0006
543 EATING DISORDER 12 0.0006
544 PALPITATIONS 66 0.0006
545 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 27 0.0006
546 BODY HEIGHT DECREASED 6 0.0006
547 THERAPEUTIC PRODUCT EFFECT DECREASED 25 0.0006
548 DIZZINESS 278 0.0006
549 ANAL INCONTINENCE 5 0.0006
550 NERVOUSNESS 29 0.0006
551 ERYTHEMA 114 0.0006
552 PHARYNGITIS STREPTOCOCCAL 6 0.0006
553 BLOOD PRESSURE ABNORMAL 11 0.0006
554 TONGUE DISORDER 4 0.0006
555 NO ADVERSE EVENT 100 0.0006
556 IMPAIRED HEALING 18 0.0005
557 MAJOR DEPRESSION 4 0.0005
558 ROTATOR CUFF SYNDROME 7 0.0005
559 AUTISM SPECTRUM DISORDER 3 0.0005
560 PNEUMONIA BACTERIAL 5 0.0005
561 WHITE BLOOD CELL COUNT DECREASED 59 0.0005
562 BRAIN NEOPLASM 5 0.0005
563 ADVERSE EVENT 50 0.0005
564 INFLAMMATION 28 0.0005
565 COUGH 152 0.0005
566 UPPER RESPIRATORY TRACT INFECTION 25 0.0005
567 CEREBRAL DISORDER 4 0.0005
568 FUNGAL INFECTION 18 0.0005
569 SKIN HAEMORRHAGE 8 0.0005
570 HEPATIC STEATOSIS 10 0.0005
571 SYSTEMIC LUPUS ERYTHEMATOSUS 19 0.0005
572 ANGIOPATHY 3 0.0005
573 RIB FRACTURE 11 0.0005
574 HEART RATE IRREGULAR 12 0.0005
575 BLOOD SODIUM DECREASED 10 0.0005
576 SCAR 9 0.0005
577 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 9 0.0005
578 QUALITY OF LIFE DECREASED 7 0.0005
579 SKIN EXFOLIATION 44 0.0005
580 HERPES VIRUS INFECTION 3 0.0005
581 BALANCE DISORDER 45 0.0005
582 HYPERVENTILATION 3 0.0005
583 APHTHOUS ULCER 4 0.0005
584 IRRITABLE BOWEL SYNDROME 11 0.0005
585 SPINAL PAIN 6 0.0005
586 VIRAL INFECTION 17 0.0005
587 MEMORY IMPAIRMENT 70 0.0005
588 CHEST DISCOMFORT 52 0.0005
589 PRODUCT DISPENSING ERROR 11 0.0005
590 BLADDER DISORDER 5 0.0005
591 RESPIRATORY TRACT CONGESTION 8 0.0005
592 INTENTIONAL PRODUCT MISUSE 44 0.0005
593 ENDOPHTHALMITIS 3 0.0005
594 SENSORY LOSS 4 0.0005
595 LOCALISED INFECTION 12 0.0005
596 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 9 0.0005
597 URTICARIA 82 0.0005
598 FALL 161 0.0005
599 GASTROINTESTINAL DISORDER 43 0.0005
600 TENDERNESS 5 0.0005
601 PETECHIAE 5 0.0005
602 FEELING JITTERY 9 0.0005
603 IMMUNODEFICIENCY 7 0.0005
604 VITAMIN D DECREASED 4 0.0005
605 SLEEP DISORDER 33 0.0005
606 MALAISE 204 0.0005
607 DRUG EFFECT DECREASED 25 0.0005
608 MUSCLE STRAIN 4 0.0005
609 HERPES SIMPLEX 3 0.0005
610 PRODUCTIVE COUGH 22 0.0005
611 SKIN LACERATION 5 0.0005
612 NODULE 6 0.0005
613 CLOSTRIDIUM DIFFICILE INFECTION 10 0.0005
614 NAIL DISORDER 4 0.0005
615 GASTRITIS 12 0.0005
616 IMMUNE SYSTEM DISORDER 6 0.0005
617 ANKYLOSING SPONDYLITIS 6 0.0005
618 TOOTH INFECTION 6 0.0005
619 HYPOGLYCAEMIA 22 0.0005
620 UNDERDOSE 33 0.0005
621 NEUROPATHY PERIPHERAL 43 0.0005
622 DENTAL CARIES 5 0.0005
623 SPINAL FRACTURE 9 0.0004
624 GAIT INABILITY 15 0.0004
625 THIRST 8 0.0004
626 BRONCHIECTASIS 3 0.0004
627 RASH 194 0.0004
628 GASTROENTERITIS VIRAL 8 0.0004
629 REBOUND EFFECT 5 0.0004
630 LIP DRY 4 0.0004
631 OBESITY 7 0.0004
632 ANXIETY 125 0.0004
633 SWELLING 41 0.0004
634 DEPRESSED MOOD 23 0.0004
635 DRY SKIN 58 0.0004
636 PNEUMONIA 140 0.0004
637 MUSCLE TIGHTNESS 7 0.0004
638 INSOMNIA 115 0.0004
639 EXTRASYSTOLES 3 0.0004
640 TREMOR 71 0.0004
641 BLOOD TEST ABNORMAL 6 0.0004
642 ARTERIOSCLEROSIS 4 0.0004
643 COVID-19 PNEUMONIA 5 0.0004
644 BRONCHOSPASM 6 0.0004
645 TREATMENT NONCOMPLIANCE 23 0.0004
646 LIMB DISCOMFORT 13 0.0004
647 DRUG DOSE OMISSION 69 0.0004
648 DERMATITIS ATOPIC 22 0.0004
649 LOWER LIMB FRACTURE 8 0.0004
650 CRYING 15 0.0004
651 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 7 0.0004
652 BURSITIS 5 0.0004
653 INTERVERTEBRAL DISC PROTRUSION 9 0.0004
654 DYSSTASIA 12 0.0004
655 HEAD INJURY 13 0.0004
656 VITAMIN D DEFICIENCY 4 0.0004
657 CHOKING 8 0.0004
658 COELIAC DISEASE 4 0.0004
659 KIDNEY INFECTION 8 0.0004
660 DECREASED IMMUNE RESPONSIVENESS 4 0.0004
661 THERAPY CHANGE 4 0.0004
662 KNEE OPERATION 4 0.0004
663 SMALL INTESTINAL OBSTRUCTION 5 0.0004
664 URINARY INCONTINENCE 12 0.0004
665 ECZEMA 21 0.0004
666 SALIVARY HYPERSECRETION 4 0.0004
667 IRRITABILITY 24 0.0004
668 BREAST TENDERNESS 3 0.0004
669 DIVERTICULITIS 11 0.0004
670 EMPHYSEMA 4 0.0004
671 LYMPHADENOPATHY 14 0.0004
672 CONTUSION 38 0.0004
673 INFLUENZA 44 0.0004
674 NAUSEA 311 0.0004
675 SLUGGISHNESS 4 0.0004
676 HIP ARTHROPLASTY 6 0.0004
677 DYSPHAGIA 37 0.0004
678 SKIN DISORDER 13 0.0004
679 OSTEOPOROSIS 16 0.0004
680 LYMPHOMA 6 0.0004
681 LUNG DISORDER 19 0.0004
682 TEMPERATURE INTOLERANCE 4 0.0004
683 TENDONITIS 6 0.0004
684 POOR VENOUS ACCESS 4 0.0004
685 AMNESIA 25 0.0004
686 RESPIRATORY TRACT INFECTION 10 0.0004
687 HEART RATE INCREASED 38 0.0004
688 GASTROINTESTINAL INFLAMMATION 3 0.0004
689 ROAD TRAFFIC ACCIDENT 16 0.0004
690 INCORRECT DOSE ADMINISTERED BY DEVICE 10 0.0004
691 MUSCLE SPASMS 70 0.0004
692 URINARY TRACT INFECTION 65 0.0004
693 SARS-COV-2 TEST POSITIVE 5 0.0004
694 THERAPY NON-RESPONDER 17 0.0004
695 CYSTITIS 12 0.0004
696 ATRIAL FLUTTER 3 0.0004
697 BREAST CANCER METASTATIC 4 0.0004
698 OFF LABEL USE 326 0.0004
699 PRODUCT USE IN UNAPPROVED INDICATION 92 0.0004
700 FRACTURE 7 0.0004
701 RASH PRURITIC 20 0.0004
702 RESPIRATORY DISORDER 11 0.0004
703 HERPES ZOSTER 21 0.0004
704 HYPERAESTHESIA 3 0.0004
705 ESCHERICHIA INFECTION 3 0.0004
706 APPLICATION SITE PAIN 8 0.0004
707 SPEECH DISORDER 19 0.0004
708 RHEUMATOID ARTHRITIS 41 0.0004
709 TOOTH DISORDER 8 0.0004
710 FEELING HOT 22 0.0004
711 HAEMORRHOIDS 7 0.0004
712 SKIN REACTION 5 0.0004
713 HAEMATOCRIT DECREASED 7 0.0004
714 NEPHROLITHIASIS 16 0.0003
715 HYPERTHYROIDISM 5 0.0003
716 ASTHMA 39 0.0003
717 NEEDLE ISSUE 10 0.0003
718 RASH MACULAR 12 0.0003
719 BLOOD CALCIUM INCREASED 3 0.0003
720 GRIP STRENGTH DECREASED 3 0.0003
721 PAIN IN EXTREMITY 100 0.0003
722 BLOOD IRON DECREASED 4 0.0003
723 POLLAKIURIA 14 0.0003
724 PULMONARY MASS 5 0.0003
725 HYPERLIPIDAEMIA 4 0.0003
726 GASTROINTESTINAL INFECTION 3 0.0003
727 KNEE ARTHROPLASTY 7 0.0003
728 MOUTH ULCERATION 7 0.0003
729 ALOPECIA 65 0.0003
730 NOCTURIA 4 0.0003
731 OSTEOPENIA 5 0.0003
732 RETCHING 7 0.0003
733 DIABETES MELLITUS 25 0.0003
734 GLOMERULAR FILTRATION RATE DECREASED 4 0.0003
735 BONE PAIN 19 0.0003
736 MUSCULOSKELETAL CHEST PAIN 5 0.0003
737 FEMUR FRACTURE 10 0.0003
738 CYST 4 0.0003
739 BLOOD CHOLESTEROL INCREASED 15 0.0003
740 APPLICATION SITE IRRITATION 4 0.0003
741 SKIN BURNING SENSATION 23 0.0003
742 DEFORMITY 3 0.0003
743 GAIT DISTURBANCE 61 0.0003
744 PAIN IN JAW 9 0.0003
745 CELLULITIS 16 0.0003
746 INFUSION RELATED REACTION 21 0.0003
747 BLOOD URINE PRESENT 6 0.0003
748 DISEASE RECURRENCE 15 0.0003
749 DYSPNOEA 178 0.0003
750 HYPERSOMNIA 9 0.0003
751 HYPOTHYROIDISM 10 0.0003
752 INJURY 22 0.0003
753 HYPOPHAGIA 8 0.0003
754 PARAESTHESIA 49 0.0003
755 CARDIAC DISORDER 29 0.0003
756 RASH GENERALISED 8 0.0003
757 MUSCULOSKELETAL STIFFNESS 27 0.0003
758 BLOOD PRESSURE SYSTOLIC INCREASED 6 0.0003
759 DEATH 264 0.0003
760 BEDRIDDEN 4 0.0003
761 INFECTION 44 0.0003
762 WHEEZING 18 0.0003
763 FATIGUE 236 0.0003
764 CONSTIPATION 66 0.0003
765 HYPERTENSION 64 0.0003
766 PANIC ATTACK 11 0.0003
767 PSYCHOMOTOR HYPERACTIVITY 5 0.0003
768 ABDOMINAL PAIN UPPER 62 0.0003
769 HYPOAESTHESIA 45 0.0003
770 FLATULENCE 17 0.0003
771 HOSPITALISATION 46 0.0003
772 MUSCULAR WEAKNESS 34 0.0003
773 MALIGNANT MELANOMA 4 0.0003
774 JOINT RANGE OF MOTION DECREASED 4 0.0003
775 EMOTIONAL DISTRESS 36 0.0003
776 BACK PAIN 69 0.0003
777 THERAPEUTIC RESPONSE DECREASED 18 0.0003
778 FEEDING DISORDER 6 0.0003
779 PRODUCT SUBSTITUTION ISSUE 17 0.0003
780 BODY TEMPERATURE INCREASED 6 0.0003
781 RASH ERYTHEMATOUS 14 0.0003
782 DEHYDRATION 39 0.0003
783 BLOOD PRESSURE FLUCTUATION 7 0.0003
784 RESPIRATORY DISTRESS 8 0.0003
785 PROCEDURAL PAIN 8 0.0003
786 MASS 4 0.0003
787 FOLLICULITIS 3 0.0003
788 PERIPHERAL SWELLING 44 0.0003
789 COLD SWEAT 5 0.0003
790 FULL BLOOD COUNT ABNORMAL 3 0.0003
791 BLOOD TRIGLYCERIDES INCREASED 5 0.0003
792 IMPAIRED WORK ABILITY 6 0.0003
793 HEREDITARY ANGIOEDEMA 3 0.0003
794 POOR QUALITY SLEEP 6 0.0003
795 DISTURBANCE IN ATTENTION 15 0.0003
796 PRURITUS GENERALISED 6 0.0003
797 CEREBROVASCULAR ACCIDENT 47 0.0003
798 BIPOLAR DISORDER 3 0.0003
799 STAPHYLOCOCCAL INFECTION 9 0.0003
800 GASTROINTESTINAL PAIN 3 0.0003
801 ARTHRALGIA 113 0.0003
802 DIARRHOEA 175 0.0003
803 COLON CANCER 4 0.0003
804 MIDDLE INSOMNIA 5 0.0003
805 TRANSIENT ISCHAEMIC ATTACK 9 0.0003
806 FLUSHING 27 0.0003
807 MUSCULOSKELETAL DISORDER 5 0.0003
808 DRUG ADMINISTRATION ERROR 8 0.0003
809 DRUG PRESCRIBING ERROR 5 0.0003
810 PAIN OF SKIN 7 0.0003
811 HERNIA 5 0.0003
812 ERUCTATION 5 0.0003
813 EXPOSURE DURING PREGNANCY 16 0.0003
814 JOINT SWELLING 31 0.0003
815 HYPOXIA 9 0.0003
816 ABNORMAL DREAMS 7 0.0003
817 ARTHROPATHY 14 0.0003
818 WEIGHT DECREASED 70 0.0003
819 INJECTION SITE BRUISING 20 0.0003
820 DEPRESSION 57 0.0003
821 SENSORY DISTURBANCE 4 0.0002
822 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 13 0.0002
823 THROMBOSIS 20 0.0002
824 NIGHT SWEATS 8 0.0002
825 MULTIPLE FRACTURES 4 0.0002
826 LETHARGY 14 0.0002
827 COAGULOPATHY 4 0.0002
828 BLOOD UREA INCREASED 4 0.0002
829 LABORATORY TEST ABNORMAL 7 0.0002
830 FLUID RETENTION 12 0.0002
831 ARRHYTHMIA 11 0.0002
832 INCORRECT PRODUCT ADMINISTRATION DURATION 5 0.0002
833 MULTIPLE SCLEROSIS 11 0.0002
834 ORTHOSTATIC HYPOTENSION 4 0.0002
835 APPLICATION SITE ERYTHEMA 6 0.0002
836 ABDOMINAL PAIN 53 0.0002
837 HEART RATE DECREASED 8 0.0002
838 DEVICE DIFFICULT TO USE 15 0.0002
839 LOSS OF CONSCIOUSNESS 29 0.0002
840 ATRIAL FIBRILLATION 22 0.0002
841 HOT FLUSH 17 0.0002
842 HAIR TEXTURE ABNORMAL 3 0.0002
843 MOBILITY DECREASED 16 0.0002
844 PSORIASIS 29 0.0002
845 MOOD ALTERED 6 0.0002
846 DECREASED APPETITE 51 0.0002
847 INFLUENZA LIKE ILLNESS 18 0.0002
848 ANAPHYLACTIC REACTION 12 0.0002
849 HYPOMAGNESAEMIA 3 0.0002
850 HUNGER 3 0.0002
851 HAEMOPTYSIS 6 0.0002
852 COGNITIVE DISORDER 10 0.0002
853 DEVICE OCCLUSION 3 0.0002
854 HALLUCINATION 16 0.0002
855 INTESTINAL OBSTRUCTION 8 0.0002
856 HYPOCALCAEMIA 4 0.0002
857 PULMONARY FIBROSIS 4 0.0002
858 TYPE 2 DIABETES MELLITUS 7 0.0002
859 PRESCRIBED OVERDOSE 4 0.0002
860 HYPOKINESIA 3 0.0002
861 CONFUSIONAL STATE 33 0.0002
862 GASTRIC DISORDER 7 0.0002
863 DISORIENTATION 8 0.0002
864 CHEST PAIN 37 0.0002
865 ASTHENIA 75 0.0002
866 GLYCOSYLATED HAEMOGLOBIN INCREASED 5 0.0002
867 HEPATITIS 5 0.0002
868 EMOTIONAL DISORDER 6 0.0002
869 TOOTH LOSS 4 0.0002
870 BASAL CELL CARCINOMA 3 0.0002
871 HEPATIC ENZYME INCREASED 13 0.0002
872 JOINT STIFFNESS 5 0.0002
873 ABSCESS 3 0.0002
874 CHILLS 22 0.0002
875 WEIGHT INCREASED 42 0.0002
876 SKIN CANCER 4 0.0002
877 BLOOD POTASSIUM INCREASED 3 0.0002
878 OEDEMA 10 0.0002
879 DEVICE DELIVERY SYSTEM ISSUE 5 0.0002
880 SKIN LESION 5 0.0002
881 TACHYCARDIA 16 0.0002
882 PULMONARY EMBOLISM 17 0.0002
883 CHROMATURIA 4 0.0002
884 AGITATION 13 0.0002
885 MYALGIA 30 0.0002
886 RED BLOOD CELL COUNT DECREASED 5 0.0002
887 PERICARDIAL EFFUSION 4 0.0002
888 ABDOMINAL DISTENSION 18 0.0002
889 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 5 0.0002
890 PYREXIA 59 0.0002
891 SYNCOPE 17 0.0002
892 GALLBLADDER DISORDER 3 0.0002
893 VOMITING 79 0.0002
894 BLOOD PRESSURE DECREASED 11 0.0002
895 PRESYNCOPE 4 0.0002
896 HAEMATOCHEZIA 9 0.0002
897 MENTAL DISORDER 7 0.0002
898 MYOCARDIAL INFARCTION 28 0.0002
899 HEPATIC CIRRHOSIS 3 0.0002
900 GASTRIC ULCER 3 0.0002
901 HAEMATEMESIS 4 0.0002
902 SUICIDAL IDEATION 14 0.0002
903 HYPOKALAEMIA 7 0.0002
904 BREAST CANCER 14 0.0002
905 URINARY RETENTION 5 0.0001
906 BLOOD GLUCOSE INCREASED 28 0.0001
907 ANGER 5 0.0001
908 DYSKINESIA 6 0.0001
909 MULTIPLE SCLEROSIS RELAPSE 10 0.0001
910 DRUG INTERACTION 23 0.0001
911 FEELING COLD 4 0.0001
912 WOUND 4 0.0001
913 OXYGEN SATURATION DECREASED 8 0.0001
914 HALLUCINATION, VISUAL 3 0.0001
915 HYPERHIDROSIS 18 0.0001
916 ANGINA PECTORIS 4 0.0001
917 SEIZURE 16 0.0001
918 C-REACTIVE PROTEIN INCREASED 5 0.0001
919 RESTLESSNESS 5 0.0001
920 ANGIOEDEMA 6 0.0001
921 LIVER DISORDER 6 0.0001
922 SEPSIS 15 0.0001
923 COLITIS ULCERATIVE 6 0.0001
924 MUSCULOSKELETAL PAIN 7 0.0001
925 DYSARTHRIA 5 0.0001
926 APPLICATION SITE PRURITUS 3 0.0001
927 LOWER RESPIRATORY TRACT INFECTION 6 0.0001
928 COLITIS 5 0.0001
929 INJECTION SITE RASH 4 0.0001
930 WHITE BLOOD CELL COUNT INCREASED 5 0.0001
931 SOMNOLENCE 26 0.0001
932 RENAL DISORDER 6 0.0001
933 INJECTION SITE HAEMORRHAGE 10 0.0001
934 HYPOTENSION 25 0.0001
935 MOVEMENT DISORDER 4 0.0001
936 CARDIAC FAILURE CONGESTIVE 10 0.0001
937 MATERNAL EXPOSURE DURING PREGNANCY 11 0.0001
938 DEVICE ISSUE 11 0.0001
939 BLOOD CREATININE INCREASED 8 0.0001
940 ACNE 9 0.0001
941 INJECTION SITE PAIN 36 0.0001
942 HAEMOGLOBIN DECREASED 12 0.0001
943 ERECTILE DYSFUNCTION 3 0.0001
944 ANAPHYLACTIC SHOCK 3 0.0001
945 NIGHTMARE 4 0.0001
946 ANAEMIA 22 0.0001
947 HAEMORRHAGE 12 0.0001
948 FREQUENT BOWEL MOVEMENTS 3 0.0001
949 DRUG EFFECT INCOMPLETE 4 0.0001
950 HYPERGLYCAEMIA 4 0.0001
951 INTENTIONAL OVERDOSE 7 0.0001
952 DYSURIA 4 0.0001
953 INCORRECT DRUG ADMINISTRATION DURATION 3 0.0001
954 DYSPNOEA EXERTIONAL 4 0.0001
955 INJECTION SITE SWELLING 8 0.0001
956 BLOOD GLUCOSE DECREASED 5 0.0001
957 ACUTE MYOCARDIAL INFARCTION 3 0.0001
958 INJECTION SITE REACTION 7 0.0001
959 BLOOD POTASSIUM DECREASED 3 0.0001
960 APHASIA 3 0.0001
961 CONTRAINDICATED PRODUCT ADMINISTERED 3 0.0001
962 BONE DENSITY DECREASED 3 0.0001
963 WITHDRAWAL SYNDROME 4 0.0001
964 RECTAL HAEMORRHAGE 4 0.0001
965 CHOLELITHIASIS 3 0.0001
966 DEVICE USE ERROR 3 0.0001
967 DEVICE MALFUNCTION 6 0.0001
968 CEREBRAL HAEMORRHAGE 3 0.0001
969 ALANINE AMINOTRANSFERASE INCREASED 5 0.0001
970 GENERAL PHYSICAL HEALTH DETERIORATION 9 0.0001
971 DISEASE PROGRESSION 9 0.0001
972 ASPARTATE AMINOTRANSFERASE INCREASED 4 0.0001
973 CARDIAC FAILURE 6 0.0001
974 INJECTION SITE PRURITUS 5 0.0001
975 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
976 INJECTION SITE ERYTHEMA 9 0.0001
977 ACUTE KIDNEY INJURY 11 0.0001
978 RENAL IMPAIRMENT 6 0.0001
979 DEVICE LEAKAGE 3 0.0001
980 CHRONIC KIDNEY DISEASE 5 0.0001
981 PLEURAL EFFUSION 4 0.0001
982 OEDEMA PERIPHERAL 8 0.0001
983 HYPONATRAEMIA 3 0.0001
984 BLADDER CANCER 3 0.0001
985 GASTROINTESTINAL HAEMORRHAGE 4 0.0000
986 RENAL FAILURE 6 0.0000
987 TOXICITY TO VARIOUS AGENTS 7 0.0000
988 THROMBOCYTOPENIA 4 0.0000